LiverMultiScan’s cT1 decreased in patients with chronic hepatitis C virus (HCV) undergoing direct-acting antiviral therapy. The fast reduction in cT1 is consistent with reduced inflammation rather than fibrosis regression, supporting LiverMultiScan as a sensitive biomarker for treatment monitoring.
Welcome to Perspectum Medical Education
You are entering a website that is scientific in nature and created for healthcare professionals.
Are you a healthcare professional?